AdvisorShares Investments LLC
Position in NEUP — Neuphoria Therapeutics Inc.
CIK 1425930
BETHESDA, MD
Position in NEUP
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,105,212
+$472,869 QoQ
Shares Held
252,909
+62.8% QoQ
Ownership
4.68%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#2
of 22 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NEUP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AdvisorShares Investments LLC holds $30,987,010 across 21 Biotechnology names. NEUP ranks #11 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
121,381 | $5,709,762 | |
| 2 | ATAI |
AtaiBeckley Inc.
|
882,892 | $4,652,840 | |
| 3 | RLMD |
Relmada Therapeutics, Inc.
|
438,901 | $3,037,194 | |
| 4 | NRXP |
NRX Pharmaceuticals, Inc.
|
659,018 | $2,695,383 | |
| 5 | HELP |
Cybin Inc.
|
292,711 | $1,934,819 | |
| 6 | GHRS |
GH Research PLC
|
71,267 | $1,915,656 | |
| 7 | ANRO |
Alto Neuroscience, Inc.
|
70,748 | $1,867,039 | |
| 8 | DRUG |
Bright Minds Biosciences Inc.
|
24,274 | $1,704,034 |
All Filings in NEUP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,105,212 | 252,909 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $632,343 | 155,367 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $520,672 | 134,194 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $690,457 | 58,563 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $480,904 | 67,733 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $401,235 | 69,659 | Shares | Sole | 2025-05-13 | |
| No filing history on record for this holder in this stock. | ||||||